Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60...

|By:, SA News Editor

Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60 a share, a 1.3% discount to Wednesday's close. The company's float stands at around 166.3M shares. ARIA plans to use the proceeds for making and marketing its leukemia treatment Iclusig and for developing its other drug candidates.